Schott, Gisela <br/><br/>
The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.  [electronic resource] 

 -  Deutsches Arzteblatt international  Apr 2010 
 - 279-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review 
<br/><br/><label>ISSN: </label>1866-0452 
<br/><br/><label>Standard No.: </label>10.3238/arztebl.2010.0279  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic--economics<br/>Conflict of Interest--economics<br/>Drug Industry--economics<br/>Ethics, Pharmacy<br/>Germany<br/>Humans<br/>Publication Bias<br/>Research Support as Topic--economics